Based on the information received, clinical evaluation confirmed the reported aneurysm enlargement.Clinical evaluation was unable to confirm the reported patient status of doing well and being on surveillance.Additionally, clinical evaluation found a type iiia -aortic endoleak with complete component separation.The most likely cause of the proximal and mid-aortic (complete component separation) loss of seal was the anterior remodeling of the aorta; however, a definitive root cause cannot be determined.There was no evidence of a secondary procedure and the patient status is unknown.Reportedly, the patient will be on surveillance.There are no further reports of negative patient sequelae.The devices remain implanted in the patient and will not be returned; therefore, device evaluation will not be completed.The review of manufacturing lot confirmed all devices met specifications prior to release.This complaint is not capa eligible at this time.These types of events will be monitored and trended as part of the quality system.
|